TICKERNERD
Menu
HCTIHCTIHealthcare · Health Information Services

HCTI Stock Forecast: Healthcare Triangle, Inc. Price Predictions for 2026-2027

Last close, 15 Sept 2026
$0.71

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 24 of 100 as at 15 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$10.9M
Ticker Nerd rank
24 / 100
Median analyst target
$3.15
Analysts covering
0
Revenue$9.2M+158.4% y/y
Operating income−$4.1M
Net income−$4.4M
Free cash flow−$864K
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Ticker Nerd rank

HCTI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Healthcare Triangle, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Sept 2026
24 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
92
Revisions
71
Growth
54
Volatility
42
Quality
32
Accruals
24
Momentum
19
Value
11
Issuance
3

Size (92): Smaller than most of the companies we track.

Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HCTI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HCTI, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 Sept 2022EF HuttonMaintainsBuy$4.00 → $2.00
14 Mar 2022EF HuttonInitiatesBuy$4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HCTI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

HCTI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Healthcare Triangle, Inc. (HCTI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.0×

Cheaper than 75% of US stocks

Price / sales
0.4×

Cheaper than 85% of US stocks

Price / book
0.1×

Cheaper than 91% of US stocks

EV / EBITDA
−3.6×

Cheaper than 76% of US stocks

Growth & margins
Revenue growth (YoY)
158.4%

Higher than 95% of US stocks

Earnings growth (YoY)
158.4%

Higher than 88% of US stocks

Gross margin
22.5%

Higher than 24% of US stocks

Operating margin
−44.3%

Higher than 18% of US stocks

Net margin
−66.3%

Higher than 8% of US stocks

Returns & dividend
Return on equity
−57.4%

Higher than 20% of US stocks

Return on assets
−20.9%

Higher than 19% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Healthcare Triangle, Inc. (HCTI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Healthcare Triangle, Inc. has a market value of $10.9M and an enterprise value of $47.5M.

  • Revenue in the twelve months to 30 June 2026: $25.7M. The latest quarter grew 158.4% year on year.

  • Net income over the same four quarters: −$17.0M, a −66.3% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$17.6M.

  • Healthcare Triangle, Inc. spent $0.0 on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 2.0M.

  • Trailing P/E: 0.0×; forward P/E: −1.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Healthcare Triangle, Inc. employs 40 people — $642K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Sept 2026

Data provided by Twelve Data

Peers

HCTI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
HCTIHealthcare Triangle, Inc.$10.9M
24
MGRXMangoceuticals, Inc.$9.1M
41
BFRGBullFrog AI Holdings, Inc.$8.3M
38
ACONAclarion, Inc.$7.6M
20
ZCMDZhongchao, Inc.$6.4M
23
BEATHeartBeam, Inc.$23.9M
19
ONMDOneMedNet Corp.$38.6M
15

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Healthcare Triangle, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HCTI news & analysis

Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.

PRNewsWire · 3 Sept 2026neutral

Healthcare Triangle, Inc. announced that its board approved a stock dividend distribution of a minority interest of outstanding common shares of its subsidiary Teyame AI Holdings Inc. to existing HCTI shareholders, in connection with a planned direct listing of Teyame AI Holdings. The transaction is subject to NASDAQ approval and follows the signing of a separation agreement between HCTI and Teyame AI Holdings.

Why it matters — HCTI shareholders will receive common shares of Teyame AI Holdings as a stock dividend as part of the planned separation and direct listing of the subsidiary, subject to NASDAQ approval.

Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026

PRNewsWire · 13 Aug 2026positive

Healthcare Triangle, Inc. reported Q2 2026 financial results showing revenue of $9.19 million, up 158% year over year, and gross profit up 322% to $2.07 million. Its AI-powered customer engagement segment contributed $6.31 million in quarterly revenue, while stockholders' equity rose to $49.1 million from $9.9 million.

Why it matters — HCTI watchers would note the significant year-over-year growth in revenue and gross profit, driven by the AI-powered customer engagement segment and a sharp increase in stockholders' equity.

HCTI's Teyame Delivers a Full Year of Client Revenue in Six Months; €2 Million in Target

PRNewsWire · 6 Aug 2026positive

Healthcare Triangle reported that its subsidiary Teyame Holdings issued a progress report showing exceptional growth for a key client, one of Spain's leading health insurance companies. The client had already matched its full-year 2025 revenue by June 2026, with annual turnover projected to reach €2 million.

Why it matters — The progress report indicates Teyame is delivering strong client growth for HCTI, with a key healthcare client reaching a full year's revenue in half a year.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

PRNewsWire · 29 July 2026positive

Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent to acquire 51% of CosmoInnovations, a move that will bring 27 granted international patents and 61 pending applications into its portfolio and expand the company into MedTech and consumer-health markets.

Why it matters — This acquisition would mark HCTI's entry into high-growth proprietary MedTech and consumer-health markets with a substantial patent portfolio and a commercial pipeline that could significantly broaden its revenue base.

Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard

PRNewsWire · 29 July 2026positive

Healthcare Triangle completed the issuance of 12,546,540 shares of common stock on July 24, 2026, relating to its acquisition of Teyame AI LLC and a Share Exchange Agreement with SecureKloud Technologies Ltd., increasing total shares outstanding to 14,644,322.

Why it matters — The share issuance provides added cushion under Nasdaq's newly effective $5 million Market Value of Listed Securities requirement, strengthening HCTI's compliance with continued listing standards.

FAQ

Frequently asked questions about HCTI stock

How does Ticker Nerd's model rank HCTI?

As at 15 Sept 2026, Healthcare Triangle, Inc. ranks 24 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (92 of 100).

What is the HCTI stock forecast for 2030?

No analyst covering Healthcare Triangle, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HCTI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3.15 to $3.15 over the next 12 months.

What does Healthcare Triangle, Inc. do?

Healthcare Triangle Inc. is a healthcare information technology company that provides digital health and technology transformation solutions for the healthcare and life sciences industry.

What is the latest news on HCTI?

The most recent item we track (PRNewsWire, 3 Sept 2026): "Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.". Healthcare Triangle, Inc. announced that its board approved a stock dividend distribution of a minority interest of outstanding common shares of its subsidiary Teyame AI Holdings Inc. to existing HCTI shareholders, in connection with a planned direct listing of Teyame AI Holdings. The transaction is subject to NASDAQ approval and follows the signing of a separation agreement between HCTI and Teyame AI Holdings.

Company

About Healthcare Triangle, Inc.

Healthcare Triangle Inc. is a healthcare information technology company that provides digital health and technology transformation solutions for the healthcare and life sciences industry. Healthcare Triangle Inc. focuses on cloud services, data science, and professional and managed services that help organizations modernize information systems, improve data use, and support personalized healthcare delivery. Its offerings span software services, managed services and support, and platform services, including tools for cloud architecture, enterprise data platforms, application modernization, and AI-enabled workflows. The company serves hospitals, health systems, payers, and pharmaceutical and life sciences organizations, supporting needs such as electronic health record operations, regulatory compliance, collaborative research, and digital transformation. Healthcare Triangle Inc. plays a role in helping healthcare organizations connect clinical and operational data with technology-driven processes across regulated healthcare environments.

CEO Mr. Anand Kumar · 40 employees · United States · https://www.healthcaretriangle.com